An estimated 1 million people in the U.S. have been diagnosed with multiple sclerosis (MS)1 and it is likely between 30 and ...

The North Chicago drugmaker says it could pay Xilio Therapeutics more than $2.1 billion in a collaboration and ...

Xilio Therapeutics shares took flight in premarket trading Wednesday after the clinical-stage biotechnology company formed a potentially lucrative collaboration with AbbVie that includes an equity ...

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell engagers, with $52.0 million in upfront payments Extended ant ...

AbbVie and Xilio Therapeutics have inked a collaboration and option-to-license agreement potentially worth more than $2 billion to clinical-stage biotechnology company Xilio.

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including ...

Having kicked off the year with a T-cell engager deal, AbbVie has returned to the modality. | Having kicked off the year with ...

A Falmouth senior netted back-to-back hat tricks, and players from Beverly/Danvers, Burlington, Milton, ...

Arturo Gatti Jr. is a tough customer, just like his late father. But the young boxer from Montreal won’t make an appearance ...

Davis Cos. has unveiled its latest plan for the Waltham property after it scrapped a lab proposal and got hit with a lawsuit from the site’s former owner.